Showing 2,801 - 2,820 results of 61,189 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (nn decrease)) ))', query time: 0.81s Refine Results
  1. 2801

    Nanodomains and Their Temperature Dependence in a Phosphonium-Based Ionic Liquid: A Single-Molecule Tracking Study by Jemima Opare-Addo (14657955)

    Published 2024
    “…Two diffusing populations were also measured for the chemically different probes ATTO 647N, DiD, and Nile Blue chloride in [P<sub>66614</sub>][Cl] at 20 °C. In contrast, only a single fast population was measured in [P<sub>66614</sub>][Cl] at 50 °C. …”
  2. 2802
  3. 2803
  4. 2804
  5. 2805
  6. 2806
  7. 2807

    3‑Hydroxyquinolin-2-Ones Act as Dual Inhibitors of Ferroptosis and Monoamine Oxidase B: Reducing Alzheimer’s Disease-Related Amyloid Precursor Protein and Hyperphosphorylated Tau I... by Yangjing Lv (21580685)

    Published 2025
    “…Compound <b>21d</b> emerged as a promising candidate, exhibiting potent and selective MAO-B inhibitory activity (IC<sub>50</sub> = 87.47 nM, SI > 229), as well as excellent antiferroptosis activity through modulation of the iron metabolic pathway and GSH-GPX4 axis in vitro<i>.…”
  8. 2808

    Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors by Stanislav Andreev (11067165)

    Published 2021
    “…Here, by addressing a high-energy water, we improved the IC<sub>50</sub> value of our co-crystallized glycogen synthase kinase-3β (GSK-3β) inhibitor by nearly two orders of magnitude. …”
  9. 2809

    Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors by Stanislav Andreev (11067165)

    Published 2021
    “…Here, by addressing a high-energy water, we improved the IC<sub>50</sub> value of our co-crystallized glycogen synthase kinase-3β (GSK-3β) inhibitor by nearly two orders of magnitude. …”
  10. 2810

    Twenty-two identified and replicated loci and their overlap with associations to metabolic traits and clinical phenotypes. by Johannes Raffler (793347)

    Published 2015
    “…<p><sup>a</sup> SNP with the strongest association to targeted metabolic traits (“lead SNP”)</p><p><sup>b</sup> SNP with the strongest association to non-targeted metabolic traits</p><p><sup>c</sup> manually added to the list of most plausible candidate genes derived by evidence-based selection</p><p><sup>d</sup> additional candidates match to other non-targeted traits that also associate with the lead SNP</p><p><sup>e</sup> results from GWAS (<i>P</i> < 5.0×10<sup>−8</sup>)</p><p><sup>f</sup> mutations determined in clinical studies</p><p>For each locus, we selected all variants that displayed genome-wide significant association signals to metabolic traits in the SHIP-0 cohort. …”
  11. 2811
  12. 2812
  13. 2813
  14. 2814
  15. 2815
  16. 2816
  17. 2817
  18. 2818
  19. 2819
  20. 2820

    Postnatal decrease in PV+ cortical interneurons in Fgfr1 mutant mice. by Karen Müller Smith (613941)

    Published 2014
    “…Scale bar is 50 µm in <b>A</b>,<b>B</b>. Stereological analysis show significant decreases in in both GFP and PV immunopositive cells in Fgfr1 mutant mice as compared to littermate controls (<b>C</b>). …”